Rachel Weihe, M.D.
Dr. Rachel Weihe is an Assistant Professor of Infectious Diseases in the Department of Internal Medicine at the University of Kansas Medical Center.
Dr. Weihe received her medical degree from the University of Kansas School of Medicine. She then completed her Internal Medicine internship and residency at Saint Louis University Hospital in St. Louis, MO. She served as chief fellow during her second year of Infectious Disease Fellowship, which she completed at the University of Kansas School of Medicine.
In addition to her clinical duties, she is actively involved in teaching and mentoring learners, serving on the infectious disease program committee, as well as the antimicrobial stewardship committee.
Education and Training
- BA, Spanish with Honors, University of Kansas, Lawrence, KS
- MD, Medical Degree, University of Kansas School of Medicine, Kansas City, KS
- Internship, Internal Medicine, Saint Louis University Hospital, Saint Louis, MO
- Residency, Internal Medicine, Saint Louis University Hospital, Saint Louis, MO
- Clinical Fellowship, Infectious Diseases, University of Kansas School of Medicine, Kansas City, KS
Licensure, Accreditations & Certifications
- Board Certification in Infectious Diseases, American Board of Internal Medicine
- Board Certification in Internal Medicine, American Board of Internal Medicine
- Missouri State Physician and Surgeon License, Missouri State Board of Registration for the Healing Arts
- Physician License, Kansas State Board of Healing Arts
- The Society of Healthcare Epidemiology of America, Member, 2020 - Present
- Antimicrobial Stewardship Committee, Member, 2019 - Present
- Infectious Disease Society of America, Member, 2016 - Present
- American Medical Association, Member, 2013 - Present
- American College of Physicians, Member, 2012 - Present
Dr. Weihe's research areas of interest include management of bone and joint infections, implementation and use of rapid microbial diagnostic testing, and quality improvement in the healthcare setting with particular focus on diagnostic stewardship.
In 2020, Dr. Weihe was a sub-investigator in 2 separate clinical trials investigating efficacy of convalescent plasma use in the management of SARS CoV 2 infection. The first was a multi-site national US Expanded Access Program for Convalescent Plasma for the Treatment of Patients with COVID-19, sponsored out of the Mayo Clinic in Rochester, MN. After the FDA approved convalescent plasma for emergency use, Dr. Weihe worked in collaboration as a sub-investigator for the PassItOn trial, a multi-site, randomized control, double blinded trial evaluating high titer convalescent donor plasma for treatment of adults hospitalized with COVID-19.
Dr. Weihe mentors learners through research studies, presentations and posters submitted to such organizations as the annual international IDWeek conference and Kansas state ACP, and as well as academic writing and other scholarly effort.